Nathan W. Bartlett
Norfolk Place
London, ENG, United Kingdom
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 79 publications
A targeted antioxidant nanomedicine regulates mitochondrial ROS and antiviral immunity in rhinovirus-infected human bronchial epithelial cells.
Journal: Drug delivery and translational research
Published: April 20, 2026
Oral lactoferrin reduces systemic inflammation, enhances anti-viral responses and modulates immune cell profiles: a randomised controlled trial in healthy, older adults.
Journal: The British journal of nutrition
Published: February 04, 2026
Pilot investigation of an oligosaccharide blend in adults with asthma - a double-blind, randomised, placebo-controlled, 4-arm crossover trial.
Journal: Respiratory medicine
Published: August 12, 2025
The Pandemic Respiratory Virus Epidemiological Surveillance Trial - A Self-swab Surveillance System for Respiratory Viruses Nested Within FluTracking.
Journal: The Journal of infectious diseases
Published: August 05, 2025
Targeting respiratory virus-induced reactive oxygen species in airways diseases.
Journal: European respiratory review : an official journal of the European Respiratory Society
Published: July 30, 2024
Human coronavirus OC43 nanobody neutralizes virus and protects mice from infection.
Journal: Journal of virology
Published: May 06, 2024
Upper Respiratory Tract OC43 Infection Model for Investigating Airway Immune-Modifying Therapies.
Journal: American journal of respiratory cell and molecular biology
Published: August 21, 2023
Mechanical forces suppress antiviral innate immune responses from asthmatic airway epithelial cells following rhinovirus infection.
Journal: American journal of physiology. Lung cellular and molecular physiology
Published: June 06, 2023
Statement in Support of: "Virology under the Microscope-a Call for Rational Discourse".
Journal: mBio
Published: April 25, 2023
Last Updated: 09/26/2026